Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a ...

The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis) to treat adults with ...

Live meetings have come a long way in recent years, but let’s face it – ‘passive listening’ is a concept best left in the ...

Don’t be simplistic with your complex problems ...

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...